4.7 Article

Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave

期刊

JOURNAL OF INFECTION
卷 65, 期 5, 页码 423-430

出版社

W B SAUNDERS CO LTD
DOI: 10.1016/j.jinf.2012.07.004

关键词

Influenza B; Influenza A(H1N1) pdm09; Pneumonia; Clinical outcomes; Mortality

资金

  1. Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III [GR09/0041]
  2. European Development Regional Fund A way to achieve Europe ERDF
  3. Spanish Network for the Research in Infectious Diseases [REIPI RD06/0008]
  4. Instituto de Salud Carlos III, Programme Miguel Servet [CP05/00226]

向作者/读者索取更多资源

Objectives: After the last pandemic the knowledge regarding influenza A infection has improved however, the outcomes of influenza B infection remain poorly studied. The aim of this study was to compare the features of influenza B versus influenza A(H1N1)pdm09 infections during the 2010-2011 epidemic-season. Methods: A prospective, observational-cohort of adults with laboratory-confirmed influenza infection during the 2010-2011 epidemic-season was studied Results: Fifty cases of influenza B and 80 of influenza A(H1N1) pdm09 infection were enrolled. Among patients with influenza B, the median age was 34 years-old (23-64), 30% pregnant, 24% obese, 34% transplant recipients and 14% with bacterial co-infection. Twenty-eight percent of patients had pneumonia with alveolar localized pattern and five (10%) died. Pneumonia was associated with delayed antiviral therapy, older age, higher Charlson score, invasive mechanical ventilation and bacterial co-infection. Obesity and pregnancy were not associated with complicated influenza B infection. The proportion of pneumonia, admission to the ICU and mortality did not differ between cases of influenza A(H1N1) pdm09 and influenza B infection. Conclusions: Influenza B infection causes severe infection and it is associated with pneumonia or death, similar to influenza A(H1N1) pdm09 infection. Rapid diagnosis and early antiviral therapy are necessary for managing influenza pneumonia during epidemic periods. (C) 2012 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy

Raquel Parra-Millan, Manuel E. Jimenez-Mejias, Rafael Ayerbe-Algaba, Juan Dominguez-Herrera, Caridad Diaz, Jose Perez del Palacio, Jeronimo Pachon, Younes Smani

Summary: The study showed that modifying immune response with LPC in murine models had a significant impact on the prognosis of infections induced by ceftazidime-resistant P. aeruginosa, compared to antibiotic therapy alone.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2022)

Article Microbiology

Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage

Alba Escalera, Ana S. Gonzalez-Reiche, Sadaf Aslam, Ignacio Mena, Manon Laporte, Rebecca L. Pearl, Andrea Fossati, Raveen Rathnasinghe, Hala Alshammary, Adriana van de Guchte, Keith Farrugia, Yiren Qin, Mehdi Bouhaddou, Thomas Kehrer, Lorena Zuliani-Alvarez, David A. Meekins, Velmurugan Balaraman, Chester McDowell, Jurgen A. Richt, Goran Bajic, Emilia Mia Sordillo, Marion Dejosez, Thomas P. Zwaka, Nevan J. Krogan, Viviana Simon, Randy A. Albrecht, Harm van Bakel, Adolfo Garcia-Sastre, Teresa Aydillo

Summary: This study characterized the spike polymorphisms of the emerging SARS-CoV-2 variants and investigated their impact on transmissibility and virus pathogenicity. The findings showed that specific substitutions enhance viral replication and spike protein cleavage, leading to increased transmission efficiency in infection models and human airway systems.

CELL HOST & MICROBE (2022)

Article Virology

Obesity and Metabolic Dysregulation in Children Provide Protective Influenza Vaccine Responses

Mundeep K. Kainth, Joanna S. Fishbein, Teresa Aydillo, Alba Escalera, Rachael Odusanya, Kalliopi Grammatikopoulos, Tiffany Scotto, Christine B. Sethna, Adolfo Garcia-Sastre, Clifford S. Deutschman

Summary: This study investigated antibody and cytokine responses following influenza vaccination in obese children. The results showed that obesity did not alter the efficacy of the vaccine, regardless of metabolic health. However, metabolically unhealthy obese children had decreased IL-13 levels, which may be associated with altered inflammatory response.

VIRUSES-BASEL (2022)

Article Cell Biology

Limited extent and consequences of pancreatic SARS-CoV-2 infection

Verena van der Heide, Sonia Jangra, Phillip Cohen, Raveen Rathnasinghe, Sadaf Aslam, Teresa Aydillo, Daniel Geanon, Diana Handler, Geoffrey Kelley, Brian Lee, Adeeb Rahman, Travis Dawson, Jingjing Qi, Darwin D'Souza, Seunghee Kim-Schulze, Julia K. Panzer, Alejandro Caicedo, Irina Kusmartseva, Amanda L. Posgai, Mark A. Atkinson, Randy A. Albrecht, Adolfo Garcia-Sastre, Brad R. Rosenberg, Michael Schotsaert, Dirk Homann

Summary: In this study, comprehensive single-cell analysis of SARS-CoV-2-infected human pancreatic islets revealed that the infection is strictly dependent on the ACE2 receptor and targets various pancreatic cell types. However, the infection is limited and non-cytopathic, causing only mild cellular perturbations and inflammatory responses. Similar outcomes were observed with endemic coronaviruses. Further evaluation is needed to determine if COVID-19-induced damage to the pancreas and immunological changes increase the risk of diabetes.

CELL REPORTS (2022)

Article Multidisciplinary Sciences

Excretion and viability of SARS-CoV-2 in feces and its association with the clinical outcome of COVID-19

Cristina Cerrada-Romero, Judith Berastegui-Cabrera, Pedro Camacho-Martinez, Josune Goikoetxea-Aguirre, Patricia Perez-Palacios, Sonia Santibanez, Maria Jose Blanco-Vidal, Adoracion Valiente, Jorge Alba, Regino Rodriguez-Alvarez, Alvaro Pascual, Jose Antonio Oteo, Jose Miguel Cisneros, Jeronimo Pachon, Inmaculada Casas-Flecha, Elisa Cordero, Francisco Pozo, Javier Sanchez-Cespedes

Summary: The study aimed to evaluate the viability of SARS-CoV-2 viral particles excreted in stools and determine if their presence is associated with an unfavorable clinical outcome. The results showed that the replicative capacity of SARS-CoV-2 in stool samples is very limited and not associated with gastrointestinal symptoms or the progression of COVID-19 patients.

SCIENTIFIC REPORTS (2022)

Article Biology

IgM-enriched immunoglobulin improves colistin efficacy in a pneumonia model by Pseudomonas aeruginosa

Tania Cebrero-Cangueiro, Gema Labrador-Herrera, Marta Carretero-Ledesma, Soraya Herrera-Espejo, Rocio Alvarez-Marin, Jeronimo Pachon, Jose Miguel Cisneros, Maria Eugenia Pachon-Ibanez

Summary: This study evaluated the efficacy of ceftazidime or colistin in combination with polyclonal IgM-enriched immunoglobulin (IgM-IG) in an experimental pneumonia model. The results showed that ceftazidime was more effective than colistin for both strains of Pseudomonas aeruginosa. Colistin plus IgM-IG had a certain reduction effect on the bacterial lung concentration of both colistin-susceptible and resistant strains, as well as the bacteremia rate of the colistin-resistant strain.

LIFE SCIENCE ALLIANCE (2022)

Article Immunology

Autoantibodies against type I IFNs in patients with critical influenza pneumonia

Qian Zhang, Andres Pizzorno, Lisa Miorin, Paul Bastard, Adrian Gervais, Tom Le Voyer, Lucy Bizien, Jeremy Manry, Jeremie Rosain, Quentin Philippot, Kelian Goavec, Blandine Padey, Anastasija Cupic, Emilie Laurent, Kahina Saker, Martti Vanker, Karita Saerekannu, Tamara Garcia-Salum, Marcela Ferres, Nicole Le Corre, Javier Sanchez-Cespedes, Maria Balsera-Manzanero, Jordi Carratala, Pilar Retamar-Gentil, Gabriela Abelenda-Alonso, Adoracion Valiente, Pierre Tiberghien, Marie Zins, Stephanie Debette, Isabelle Meyts, Filomeen Haerynck, Riccardo Castagnoli, Luigi D. Notarangelo, Luis I. Gonzalez-Granado, Nerea Dominguez-Pinilla, Evangelos Andreakos, Vasiliki Triantafyllia, Carlos Rodriguez-Gallego, Jordi Sole-Violan, Jose Juan Ruiz-Hernandez, Felipe Rodriguez de Castro, Jose Ferreres, Marisa Briones, Joost Wauters, Lore Vanderbeke, Simon Feys, Chen-Yen Kuo, Wei-Te Lei, Cheng-Lung Ku, Galit Tal, Amos Etzioni, Suhair Hanna, Thomas Fournet, Jean-Sebastien Casalegno, Gregory Queromes, Laurent Argaud, Etienne Javouhey, Manuel Rosa-Calatrava, Elisa Cordero, Teresa Aydillo, Rafael A. Medina, Kai Kisand, Anne Puel, Emmanuelle Jouanguy, Laurent Abel, Aurelie Cobat, Sophie Trouillet-Assant, Adolfo Garcia-Sastre, Jean-Laurent Casanova

Summary: In a study of 279 international patients with hypoxemic influenza pneumonia, 4.6% of patients were found to have autoantibodies neutralizing IFN-alpha and/or -omega, which may contribute to life-threatening COVID-19 pneumonia and severe adverse reactions to yellow fever vaccine. These antibodies increased influenza virus replication and were more prevalent in patients under 70 years old compared to the general population. Patients with high concentrations of both IFN-alpha 2 and IFN-omega antibodies had the highest risk of critical influenza.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Immunology

Immunodominance hierarchy after seasonal influenza vaccination

Laura Sanchez-de Prada, Ivan Sanz-Munoz, Raul Ortiz de Lejarazu, Jose Maria Eiros, Adolfo Garcia-Sastre, Teresa Aydillo

Summary: Current influenza vaccines induce humoral immune responses against the HA protein, with Sb and Ca2 antigenic sites showing high immunodominance. Elderly individuals have lower pre-vaccination antibody levels, while young adults have lower levels only at the Sb and Ca2 sites. After vaccination, ATIV reduces humoral responses to all viruses, while QIV only reduces responses to Sb and Ca2.

EMERGING MICROBES & INFECTIONS (2022)

Article Infectious Diseases

Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis

Soraya Herrera-Espejo, Ester Del Barrio-Tofino, Tania Cebrero-Cangueiro, Carla Lopez-Causape, Rocio Alvarez-Marin, Jose Miguel Cisneros, Jeronimo Pachon, Antonio Oliver, Maria Eugenia Pachon-Ibanez

Summary: In the context of difficult-to-treat carbapenem-resistant Pseudomonas aeruginosa infections, carbapenem combinations were found to have limited efficacy. Meropenem monotherapy showed better in vivo efficacy, possibly due to sufficient antimicrobial exposure at the infection sites.

ANTIBIOTICS-BASEL (2022)

Article Immunology

Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination

Teresa Aydillo, Ana S. Gonzalez-Reiche, Daniel Stadlbauer, Mary Anne Amper, Venugopalan D. Nair, Chiara Mariottini, Stuart C. Sealfon, Harm van Bakel, Peter Palese, Florian Krammer, Adolfo Garcia-Sastre

Summary: In this study, a phase 1 clinical trial was conducted to test the immunogenicity of a chimeric group 1 HA universal influenza virus vaccine. The results showed that vaccination with adjuvanted-inactivated vaccines induced an upregulation of genes involved in innate immune responses and type I interferon signaling. This study provides valuable insights into immune responses and gene expression regulation induced by the vaccine.

NPJ VACCINES (2022)

Article Immunology

Group 1 and group 2 hemagglutinin stalk antibody response according to age

Laura Sanchez-de Prada, Ivan Sanz-Munoz, Weina Sun, Peter Palese, Raul Ortiz de Lejarazu, Jose Maria Eiros, Adolfo Garcia-Sastre, Teresa Aydillo

Summary: Objective: The study investigated the induction of HA stalk-specific antibodies after seasonal influenza vaccination, considering the age of the cohorts. The results showed that there were differences in the antibody responses among different age groups, with lower responses observed in older individuals.

FRONTIERS IN IMMUNOLOGY (2023)

Article Multidisciplinary Sciences

Analysis of bacterial pangenomes reduces CRISPR dark matter and reveals strong association between membranome and CRISPR-Cas systems

Alejandro Rubio, Maximilian Sprang, Andres Garzon, Antonio Moreno-Rodriguez, Maria Eugenia Pachon-Ibanez, Jeronimo Pachon, Miguel A. Andrade-Navarro, Antonio J. Perez-Pulido

Summary: CRISPR-Cas systems are a type of acquired immunity found in 40% of bacterial genomes, which use small DNA fragments called spacers to prevent viral infections. However, the majority of these spacers, known as CRISPR dark matter, have not been associated with specific viruses. Through analyzing spacers from tens of thousands of genomes, researchers have reduced the amount of CRISPR dark matter from 80% to as low as 15% in some bacterial species. Additionally, it has been observed that genomes with CRISPR-Cas systems also have specific sets of membrane proteins, suggesting a connection between bacterial competitiveness and the acquisition of CRISPR-Cas.

SCIENCE ADVANCES (2023)

Article Infectious Diseases

Role of bla(TEM) and OmpC in the piperacillin-tazobactam resistance evolution by E. coli in patients with complicated intra-abdominal infection

Lydia Galvez-Benitez, Jose Manuel Ortiz de la Rosa, Angel Rodriguez-Villodres, Carlos S. Casimiro-Soriguer, Irene Molina-Panadero, Rocio Alvarez-Marin, Remy A. Bonnin, Thierry Naas, Jeronimo Pachon, Jose Miguel Cisneros, Jose Antonio Lepe, Younes Smani

Summary: This study aimed to identify the mechanisms underlying Piperacillin-tazobactam resistance (P/T-R) in Escherichia coli. The results showed that P/T-R isolates had a higher copy number of the bla(TEM) gene, generated by three different genetic events. In addition, reduced expression of OmpC was observed in two P/T-R strains. This study provides important insights into the acquisition of P/T-R in E. coli, which is crucial for effective treatment and prevention of resistant microorganisms.

JOURNAL OF INFECTION (2023)

Article Immunology

Lipid signatures of West Nile virus infection unveil alterations of sphingolipid metabolism providing novel biomarkers

Patricia Mingo-Casas, Javier Sanchez-Cespedes, Ana-Belen Blazquez, Josefina Casas, Maria Balsera-Manzanero, Laura Herrero, Ana Vazquez, Jeronimo Pachon, Manuela Aguilar-Guisado, Jose Miguel Cisneros, Juan-Carlos Saiz, Miguel A. Martin-Acebes

Summary: West Nile virus (WNV) is a neurotropic flavivirus transmitted by mosquitoes and can cause severe diseases. By studying experimentally infected mice and naturally infected patients, dynamic alterations in the lipidome were identified as metabolic fingerprints of different infection stages. The dysregulation of sphingolipid metabolism by WNV may provide new therapeutic opportunities and support the potential of certain lipids as novel peripheral biomarkers of WND progression.

EMERGING MICROBES & INFECTIONS (2023)

Article Microbiology

iTRAQ-Based Quantitative Proteomic Analysis of Acinetobacter baumannii under Hypoxia and Normoxia Reveals the Role of OmpW as a Virulence Factor

Maria Luisa Gil-Marques, Jeronimo Pachon, Younes Smani

Summary: A. baumannii needs to adapt to hypoxia during infection. This study revealed differential expression of proteins, including the virulence factor OmpW, under hypoxia, highlighting its importance in A. baumannii pathogenesis.

MICROBIOLOGY SPECTRUM (2022)

暂无数据